![Quiver Logo](/static/img/logo-icon.png)
![SONN logo](https://quiver-logos.s3.us-east-2.amazonaws.com/sonn.png)
Sonnet BioTherapeutics Holdings, Inc. Common Stock
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SONN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of SONN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SONN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to SONN
Recent picks made for SONN stock on CNBC
ETFs with the largest estimated holdings in SONN
Flights by private jets registered to SONN
![Quiver Logo](/static/img/logo-icon.png)